Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/29205311/ below:

Disparities in breast cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study

Affiliations

• ¹ Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
• ² Kentucky Cancer Registry, University of Kentucky, Lexington, Kentucky.
• ³ Cancer Survival Group, Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.

• PMID: 29205311
• PMCID: PMC5826549
• DOI: 10.1002/cncr.30988

Item in Clipboard

Jacqueline W Miller et al. Cancer. 2017.

• ¹ Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
• ² Kentucky Cancer Registry, University of Kentucky, Lexington, Kentucky.
• ³ Cancer Survival Group, Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.

• PMID: 29205311
• PMCID: PMC5826549
• DOI: 10.1002/cncr.30988

Item in Clipboard

Background: Reducing breast cancer incidence and achieving equity in breast cancer outcomes remains a priority for public health practitioners, health care providers, policy makers, and health advocates. Monitoring breast cancer survival can help evaluate the effectiveness of health services, quantify inequities in outcomes between states or population subgroups, and inform efforts to improve the effectiveness of cancer management and treatment.

Methods: We analyzed breast cancer survival using individual patient records from 37 statewide registries that participated in the CONCORD-2 study, covering approximately 80% of the US population. Females were diagnosed between 2001 and 2009 and were followed through December 31, 2009. Age-standardized net survival at 1 year, 3 years, and 5 years after diagnosis was estimated by state, race (white, black), stage at diagnosis, and calendar period (2001-2003 and 2004-2009).

Results: Overall, 5-year breast cancer net survival was very high (88.2%). Survival remained remarkably high from 2001 through 2009. Between 2001 and 2003, survival was 89.1% for white females and 76.9% for black females. Between 2004 and 2009, survival was 89.6% for white females and 78.4% for black females.

Conclusions: Breast cancer survival was more than 10 percentage points lower for black females than for white females, and this difference persisted over time. Reducing racial disparities in survival remains a challenge that requires broad, coordinated efforts at the federal, state, and local levels. Monitoring trends in breast cancer survival can highlight populations in need of improved cancer management and treatment. Cancer 2017;123:5100-18. Published 2017. This article is a U.S. Government work and is in the public domain in the USA.

Keywords: breast cancer; health disparities; population-based survival; trends.

Published 2017. This article is a U.S. Government work and is in the public domain in the USA.

PubMed Disclaimer

CONFLICT OF INTEREST DISCLOSURES

The authors made no disclosures.

Breast cancer 5-year age-standardized net…

Breast cancer 5-year age-standardized net survival (%) is illustrated for females (ages 15–99…

Breast cancer 5-year age-standardized net survival (%) is illustrated for females (ages 15–99 years) diagnosed 2001–2003 and 2004–2009 along with absolute changes (%). States are grouped by US Census region. Note that data from 37 statewide cancer registries (covering 80.6% of the population) are ranked within US Census region by the survival estimate for 2004–2009. Dark bars denote states funded by the Centers for Disease Control and Prevention National Program of Cancer Registries; pale bars, states funded by the National Cancer Institute’s Surveillance, Epidemiology and End Results Program. Asterisks indicate states that are funded by both federal surveillance programs. Change (%) was not plotted if a survival estimate was not available for 1 calendar period or if 1 or more estimates were not age standardized.

Breast cancer 5-year age-standardized net…

Breast cancer 5-year age-standardized net survival (%) is illustrated for females (ages 15–99…

Breast cancer 5-year age-standardized net survival (%) is illustrated for females (ages 15–99 years) by state, race, and calendar period of diagnosis. Note that the pooled US survival estimate for each calendar period is indicated by the solid horizontal line with corresponding 95.0% and 99.8% control limits (dashed lines).

• Colon cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.

  White A, Joseph D, Rim SH, Johnson CJ, Coleman MP, Allemani C. White A, et al. Cancer. 2017 Dec 15;123 Suppl 24(Suppl 24):5014-5036. doi: 10.1002/cncr.31076. Cancer. 2017. PMID: 29205304 Free PMC article.

• Rectal cancer survival in the United States by race and stage, 2001 to 2009: Findings from the CONCORD-2 study.

  Joseph DA, Johnson CJ, White A, Wu M, Coleman MP. Joseph DA, et al. Cancer. 2017 Dec 15;123 Suppl 24(Suppl 24):5037-5058. doi: 10.1002/cncr.30882. Cancer. 2017. PMID: 29205308 Free PMC article.

• Disparities in ovarian cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study.

  Stewart SL, Harewood R, Matz M, Rim SH, Sabatino SA, Ward KC, Weir HK. Stewart SL, et al. Cancer. 2017 Dec 15;123 Suppl 24(Suppl 24):5138-5159. doi: 10.1002/cncr.31027. Cancer. 2017. PMID: 29205312 Free PMC article.

• Lung cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.

  Richards TB, Henley SJ, Puckett MC, Weir HK, Huang B, Tucker TC, Allemani C. Richards TB, et al. Cancer. 2017 Dec 15;123 Suppl 24(Suppl 24):5079-5099. doi: 10.1002/cncr.31029. Cancer. 2017. PMID: 29205305 Free PMC article.

• Stomach cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.

  Jim MA, Pinheiro PS, Carreira H, Espey DK, Wiggins CL, Weir HK. Jim MA, et al. Cancer. 2017 Dec 15;123 Suppl 24(Suppl 24):4994-5013. doi: 10.1002/cncr.30881. Cancer. 2017. PMID: 29205310 Free PMC article.

• Assessing trends of breast cancer and carcinoma in situ to monitor screening policies in developing settings.

  Brito ÉAC, Lima MS, Siqueira HFF, Marques AD, Moura AR, Hora EC, Lima CA, Santos MO, de Souza MC, da Silva AM, Brito HLF, Cipolotti R. Brito ÉAC, et al. Sci Rep. 2019 Oct 2;9(1):14144. doi: 10.1038/s41598-019-50504-6. Sci Rep. 2019. PMID: 31578436 Free PMC article.

• Perceived risk of colorectal and breast cancers among women who are overweight or with obesity.

  Hall IJ, Soman A, Smith JL, White A, Crawford A. Hall IJ, et al. Prev Med Rep. 2019 Mar 22;14:100845. doi: 10.1016/j.pmedr.2019.100845. eCollection 2019 Jun. Prev Med Rep. 2019. PMID: 31008025 Free PMC article.

• Ethnoracial and social trends in breast cancer staging at diagnosis in Brazil, 2001-14: a case only analysis.

  Dos-Santos-Silva I, De Stavola BL, Renna NL Junior, Nogueira MC, Aquino EML, Bustamante-Teixeira MT, Azevedo E Silva G. Dos-Santos-Silva I, et al. Lancet Glob Health. 2019 Jun;7(6):e784-e797. doi: 10.1016/S2214-109X(19)30151-2. Lancet Glob Health. 2019. PMID: 31097280 Free PMC article.

• Targeting long non-coding RNA MALAT1 reverses cancerous phenotypes of breast cancer cells through microRNA-561-3p/TOP2A axis.

  Hajibabaei S, Nafissi N, Azimi Y, Mahdian R, Rahimi-Jamnani F, Valizadeh V, Rafiee MH, Azizi M. Hajibabaei S, et al. Sci Rep. 2023 May 27;13(1):8652. doi: 10.1038/s41598-023-35639-x. Sci Rep. 2023. PMID: 37244966 Free PMC article.

• Changing trends and disparities in 5-year overall survival of women with invasive breast cancer in the United States, 1975-2015.

  Yang M, Hu X, Bao W, Zhang X, Lin Y, Stanton S, Haffty B, Hu W, Kang Y, Wei S, Zhang L. Yang M, et al. Am J Cancer Res. 2021 Jun 15;11(6):3201-3211. eCollection 2021. Am J Cancer Res. 2021. PMID: 34249455 Free PMC article.

1. 1. International Agency for Research on Cancer (IARC) GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. Lyon, France: IARC; 2013. [Accessed April 12, 2016]. Available at: http://globo-can.iarc.fr/Pages/fact_sheets_cancer.aspx.
2. 1. US Cancer Statistics Working Group. US Cancer Statistics: 1999–2013 Incidence and Mortality Web-based Report. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2016. [Accessed December 9, 2016]. Available at: www.cdc.gov/uscs.
3. 1. Ryerson AB, Eheman CR, Altekruse SF, et al. Annual Report to the Nation on the Status of Cancer, 1975–2012, featuring the increasing incidence of liver cancer. Cancer. 2016;122:1312–1337. - PMC - PubMed
4. 1. US Department of Health and Human Services (HHS) HHS Action Plan to Reduce Racial and Ethnic Health Disparities: A Nation Free of Disparities in Health and Health Care. Washington, DC: HHS; 2015. [Accessed April 10, 2016]. Available at: http://minorityhealth.hhs.gov/npa/files/plans/hhs/hhs_plan_complete.pdf.
5. 1. Agency for Healthcare Research and Quality (AHRQ) National Healthcare Quality & Disparities Report Chartbooks. Rockville, MD: AHRQ, S Department of Health and Human Services; 2016. [Accessed April 13, 2016]. Available at: http://www.ahrq.gov/research/findings/nhqrdr/chart-books/index.html.

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3